Chronic Myelogenous Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
2022-01-10
Jan 10, 2022
N
Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Active, not recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +2 more
  • Augusta, Georgia
  • +29 more
2021-12-16
Dec 16, 2021
V
Allogeneic Stem Cell Transplantationin Relapsed Hematological Malignancy: Early GVHD Prophylaxis
Active, not recruiting
  • Hodgkin's Lymphoma
  • +17 more
  • mycophenolate mofetil
  • +2 more
  • Richmond, Virginia
    Virginia Commonwealth University/Massey Cancer Center
2021-12-21
Dec 21, 2021
M
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Recruiting
  • Chronic Myelogenous Leukemia
  • Chart Review
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
2021-11-24
Nov 24, 2021
N
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP.
Recruiting
  • Chronic Myelogenous Leukemia
  • ABL001 40mg BID
  • +2 more
  • Linz, Austria
  • +8 more
2021-12-03
Dec 3, 2021
C
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Recruiting
  • Acute Lymphoblastic Leukemia
  • +7 more
  • Duarte, California
  • +10 more
2021-12-02
Dec 2, 2021
N
Asciminib Roll-over Study
Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Asciminib single agent
  • +6 more
  • (no location specified)
2021-11-25
Nov 25, 2021
N
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +86 more
2021-11-16
Nov 16, 2021
W
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Recruiting
  • Acute Myelogenous Leukemia
  • +9 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Health
    2021-11-23
    Nov 23, 2021
    H
    Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention - 2021
    Completed
    Has Results
    • Chronic Myelogenous Leukemia
    • Therapy for Targeted Therapy-related Fatigue (TTF)
    • Wait-List Control Condition (WLC)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2021-11-15
    Nov 15, 2021
    N
    Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
    Active, not recruiting
    Has Results
    • Chronic Myelogenous Leukemia
    • Nilotinib followed by treatment-free
    • Fort Myers, Florida
    • +113 more
    2021-11-11
    Nov 11, 2021
    M
    UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
    Recruiting
    • Acute Leukemia
    • +24 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-11-04
    Nov 4, 2021
    S
    Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
    Recruiting
    • Allogeneic Hematopoietic Cell Transplantation (HCT)
    • +5 more
    • Purified regulatory T-cells (Treg) plus CD34+ HSPC
    • +7 more
    • Stanford, California
      Stanford University
    2021-10-28
    Oct 28, 2021
    M
    Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +17 more
    • Minneapolis, Minnesota
      University of Minnesota Masonic Cancer Center
    2021-10-27
    Oct 27, 2021
    M
    Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) - 2014
    Completed
    Has Results
    • Acute Myelogenous Leukemia
    • +4 more
    • Single Umbilical Cord Blood Unit Transplant
    • +6 more
    • Birmingham, Alabama
    • +37 more
    2021-10-13
    Oct 13, 2021
    M
    Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. - 2021
    Completed
    • Leukemia
    • +4 more
    • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-10-18
    Oct 18, 2021
    H
    Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
    Recruiting
    • Chronic Myelogenous Leukemia
    • Amman, Jordan
    • +4 more
    2021-09-01
    Sep 1, 2021
    N
    Reduced Intensity Conditioning Transplant Using Haploidentical Donors - 2020
    Completed
    • Chronic Myelogenous Leukemia
    • +9 more
    • Atlanta, Georgia
      Northside Hospital
    2021-08-30
    Aug 30, 2021
    E
    Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell
    Recruiting
    • Myeloid Leukemia, Chronic
    • +8 more
    • Conventional T cells (Tcon) and Regulatory T cells (Treg)
    • Palo Alto, California
      Stanford University School of Medicine Palo Alto, California, Un
    2021-08-18
    Aug 18, 2021
    H
    Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
    Recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    2021-08-16
    Aug 16, 2021
    M
    Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
    Active, not recruiting
    • Acute Myeloid Leukemia
    • +10 more
    • Fludarabine (FLU)
    • +8 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2021-08-13
    Aug 13, 2021
    C
    Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • +9 more
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    2021-08-04
    Aug 4, 2021
    B
    Administration of Donor T Cells With the Caspase-9 Suicide Gene
    Active, not recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • iCaspase9-transduced T cells
    • AP1903
    • Houston, Texas
    • +1 more
    2021-08-06
    Aug 6, 2021
    C
    Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
    Active, not recruiting
    • Acute Lymphoblastic Leukemia/Lymphoma
    • +4 more
      • Scottsdale, Arizona
      • +31 more
      2021-07-26
      Jul 26, 2021
      B
      CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
      Not yet recruiting
      • Hematologic Diseases
      • +5 more
      • CliniMACS
      • +7 more
      • Miami, Florida
        Miami Cancer Institute at Baptist Health, Inc.
      2021-07-21
      Jul 21, 2021